Literature DB >> 3178147

Quantitation of adriamycin content by a sensitive immunochemical assay.

G Citro1, A Verdina, R Galati, A Floridi.   

Abstract

An immunoenzymatic method for the quantitation of adriamycin (ADM) content in tissues as well as in tumor cells has been developed. This procedure has three main advantages. Firstly, it is possible to carry out the determination on whole homogenates and blood serum, thus avoiding the extractive procedures. Secondly, very low ADM concentrations (0.2 ng) can be detected. Thirdly, it is possible to determine simultaneously and in triplicate both the standard curve and ADM concentration in twelve different samples with a great reduction of the experimental variability.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3178147

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Effects of the association of adriamycin with the polar solvent N-methylformamide on human melanoma cultured cells.

Authors:  G Zupi; G Citro; C Cucco; A Molinari; A Calcabrini; M Marangolo; G Arancia
Journal:  Cytotechnology       Date:  1991-02       Impact factor: 2.058

2.  Reversal of adriamycin resistance by lonidamine in a human breast cancer cell line.

Authors:  G Citro; C Cucco; A Verdina; G Zupi
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.